100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome with Diarrhea Exam | Questions & Answers (100 %Score) Latest Updated 2024/2025 Comprehensive Questions A+ Graded Answers | With Expert Solutions $13.48   Add to cart

Exam (elaborations)

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome with Diarrhea Exam | Questions & Answers (100 %Score) Latest Updated 2024/2025 Comprehensive Questions A+ Graded Answers | With Expert Solutions

 4 views  0 purchase
  • Course
  • Irritable Bowel Syndrome
  • Institution
  • Irritable Bowel Syndrome

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome with Diarrhea Exam | Questions & Answers (100 %Score) Latest Updated 2024/2025 Comprehensive Questions A+ Graded Answers | With Expert Solutions

Preview 2 out of 7  pages

  • August 4, 2024
  • 7
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • Irritable Bowel Syndrome
  • Irritable Bowel Syndrome
avatar-seller
VasilyKichigin
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel
Syndrome with Diarrhea Exam | Questions & Answers (100 %Score) Latest Updated
2024/2025 Comprehensive Questions A+ Graded Answers | With Expert Solutions


Irritable Bowel Syndrome - ✔✔Common disorder of gut-brain interaction with 4.1%-10.1% worldwide
prevalence among adults.



Quality of Life - ✔✔Patients with IBS have worse health-related QOL than patients with diabetes or end-
stage renal disease.



IBS-D - ✔✔Irritable bowel syndrome with predominant diarrhea, affecting 30%-40% of IBS cases.



Eluxadoline - ✔✔Minimally absorbed mixed m- and k-opioid receptor agonist and d-opioid receptor
antagonist for IBS-D.



Rifaximin - ✔✔Nonabsorbable, oral antibiotic for IBS-D, FDA-approved at 550 mg 3 times per day for 14
days.



Sphincter of Oddi spasm - ✔✔A condition associated with rifaximin, contraindicated in patients with a
history of alcohol abuse.



Selective Serotonin Reuptake Inhibitors - ✔✔Conditionally not suggested for use in patients with IBS.



Antispasmodics - ✔✔Conditionally suggested for use in patients with IBS.



Grading of Recommendations Assessment, Development, and Evaluation (GRADE) - ✔✔Framework used
to assess evidence and make recommendations.



Evidence-to-Decision Framework - ✔✔Used to develop recommendations based on evidence, patient
values, and preferences.

, PICO format - ✔✔Format used to outline patient population, intervention, comparator, and outcome(s)
for each clinical question.



FDA Responder End Point for IBS-D - ✔✔Defined as a participant reporting a 30% reduction in average
daily worst abdominal pain scores and a 50% reduction in number of days per week with at least 1 stool
that has a consistency of type 6 or 7.



European Medicines Agency Responder End Point - ✔✔Similar to the FDA responder end point, but for
13 of 26 weeks.



Bristol Stool Form Scale (BSFS) - ✔✔Scale used to measure stool consistency, with type 6 or 7 indicating
diarrhea.



Rome IV Criteria - ✔✔Symptom-based diagnostic criteria for IBS.



Contraindicated - ✔✔Not recommended due to potential harm or adverse effects.



Moderate Certainty - ✔✔Level of confidence in the effect estimate, likely close to the true effect but
with a possibility of substantial difference.



Very Low Certainty - ✔✔Very little confidence in the effect estimate, likely to be substantially different
from the estimate of effect.



Primary Care - ✔✔Health care professionals providing basic medical services for common illnesses and
preventive care.



Gastroenterology Health Care Professionals - ✔✔Specialized health care professionals focusing on the
digestive system.



Policy Makers - ✔✔Individuals involved in the development and implementation of health care policies.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller VasilyKichigin. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $13.48. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

73773 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$13.48
  • (0)
  Add to cart